Castle Biosciences Supports Nationwide Patient Advocacy and Screening Initiatives to Celebrate Skin Cancer Awareness Month
Castle Biosciences announced its participation in nationwide advocacy and screening initiatives for Skin Cancer Awareness Month, collaborating with organizations like AIM at Melanoma and The Skin Cancer Foundation. The company will support events including the Champions for Change Gala in New York City and community skin checks in Nevada and California through May.
Key figures
- Patient samples validated
- more than 10,000
- Peer reviewed publications
- 58
- Tests ordered since launch
- more than 230,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.